GLYCOMIMETICS INC (GLYC)
US38000Q1022 - Common Stock
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
These stocks are moving in today's pre-market session
Stay updated with the stocks that are on the move in Monday's pre-market session.
These stocks are moving in today's after hours session
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, CPTN, GLYC, ARC on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE and GLYC on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
GLYC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of GlycoMimetics, Inc. Is Fair to Shareholders
GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma
GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint
GlycoMimetics Announces Strategic Review and Corporate Restructuring Plan
7 Sorry Biotech Stocks Set to Make Investors Sad
Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!
GLYC Stock Earnings: GlycoMimetics Misses EPS for Q1 2024
GLYC stock results show that GlycoMimetics missed analyst estimates for earnings per share the first quarter of 2024.
GLYC Stock Earnings: GlycoMimetics Misses EPS for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips GlycoMimetics (NASDAQ:GLYC) just reported results for the first quarter of 2024...
Why Is Acutus Medical (AFIB) Stock Down 41% Today?
Acutus Medical stock is down on Monday after the company reported a delisting notice that will hit AFIB shares later this week.
Why Is GlycoMimetics (GLYC) Stock Down 77% Today?
GlycoMimetics stock is falling on Monday with heavy trading of GLYC after posting lackluster results from a Phase 3 trial of uproleselan.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Monday morning!
